Haploidentical hematopoietic stem cell transplantation as promising therapy in the improved survival of pediatric patients with leukemias and myelodysplasias

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Meta-Anal. Jun 18, 2023; 11(5): 181-195
Published online Jun 18, 2023. doi: 10.13105/wjma.v11.i5.181

Full Size Figure Download Figure

Figure 1 Flowchart of studies selected for inclusion in the review following Preferred Reporting Items for Systematic Reviews.

Citation: Cardoso Brito ACC, Oliveira Carneiro Ribeiro E, Freire de Melo F. Haploidentical hematopoietic stem cell transplantation as promising therapy in the improved survival of pediatric patients with leukemias and myelodysplasias. World J Meta-Anal 2023; 11(5): 181-195
URL: https://www.wjgnet.com/2308-3840/full/v11/i5/181.htm
DOI: https://dx.doi.org/10.13105/wjma.v11.i5.181

Cardoso Brito ACC, Oliveira Carneiro Ribeiro E, Freire de Melo F. Haploidentical hematopoietic stem cell transplantation as promising therapy in the improved survival of pediatric patients with leukemias and myelodysplasias. World J Meta-Anal 2023; 11(5): 181-195 [DOI: 10.13105/wjma.v11.i5.181]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.